@inproceedings{inproceedings, title  = {{Comparative effectiveness of autologous haematopoietic stem cell transplantation vs. fingolimod, ocrelizumab and natalizumab in relapsing-remitting MS}},

 url = {{}},

 year = {{2022}},

 month = {{1}},

 author = {{Kalincik T and Sharman S and Roos I and Freedman M and Atkins H and Burman J and Massey J and Sutton I and Withers B and Macdonell R and Grigg A et al}},

 volume = {{28}},

 journal = {{MULTIPLE SCLEROSIS JOURNAL}},

 issue = {{3_SUPPL}},

 pages = {{11-14}},

 note = {{Accessed on 2024/12/22}}}